How much can treatment reduce national drug problems?

Addiction

Volumn 101, Issue 3, 2006, Pages 341-347

  Reuter, Peter ^a,c   Pollack, Harold ^b  

^a RAND CORPORATION   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

^c UNIVERSITY OF MARYLAND   (United States)

Author keywords

Drug policy; Enforcement; Harm reduction; Prevalance; Prevention; Treatment

Indexed keywords

METHADONE;

ARTICLE; COST EFFECTIVENESS ANALYSIS; CRIME; DRUG ABUSE; DRUG DEPENDENCE; HEALTH CARE COST; HUMAN; LAW; LAW ENFORCEMENT; POLICY;

HARM REDUCTION; HEALTH POLICY; HUMANS; PREVALENCE; SOCIAL CONTROL, FORMAL; SUBSTANCE-RELATED DISORDERS; TREATMENT OUTCOME; UNITED STATES;

EID: 33644758145     PISSN: 09652140     EISSN: 13600443     Source Type: Journal    
DOI: 10.1111/j.1360-0443.2005.01313.x     Document Type: Article

References (34)

1. Boyum D. Reuter P. 2005 An Analytic Assessment of US Drug Policy Washington, DC AEI Press
2. Cartwright WS. 1998 Cost-benefit and cost-effectiveness analysis of drug abuse treatment services Evaluation Review 22 609 636
3. Caulkins J. Crawford G. Reuter P. 1993 Simulation of adaptive response: a model of interdictor-smuggler interactions Computer and Mathematical Modelling 17 37 52
4. Caulkins J. Rydell CP. Everingham S. Chiesa J. Bushway S. 1999 An Ounce of Prevention, A Pound of Uncertainty Santa Monica, CA RAND Corporation.
5. Centers for Disease Control and Prevention (CDC) 2003 HIV diagnoses among injection-drug users in states with HIV surveillance - 25 states, 1994-2000 Mortality & Morbidity Weekly Report 52 634 636
6. Crane BD. Rivolo AR. Comfort GC. 1997 An Empirical Examination of Counterdrug Program Effectiveness IDA Paper P-3219. Alexandria Institute for Defense Analysis.
7. Cunningham J. Liu L-M. 2003 Impacts of federal ephedrine and pseudoephedrine regulations on methamphetamine related hospital admissions Addiction 98 1229 1237
8. Degenhart L. Reuter P. Collins L. W. Hall 2005 Evaluating factors responsible for Australia's heroin shortage Addiction 100 459 469
9. Emmanuelli J. Desenclos J-C. 2005 Harm reduction interventions, behaviours and associated health outcomes in France, 1996-2003 Addiction 100 1690 1700
10. Flynn PM. Porto JV. Rounds-Bryant JL. Kristiansen PL. 2003 Costs and benefits of methadone treatment in DATOS - Part 1. Discharged versus continuing patients Journal of Maintenance in the Addictions 2 129 149
11. French M. Roebuck M. Kebreau A. 2004 To test or not to test: do workplace drug testing programs discourage employee drug use? Social Science Research 33 45 63
12. Godfrey C. Stewart D. Gossop M. 2004 Economic analysis of costs and consequences of the treatment of drug misuse: 2-year outcome data from the National Treatment Outcome Research Study (NTORS) Addiction 99 697 707
13. Gossop M. Marsden J. Stewart D. 1999 NTORS at One Year London Department of Health Available at:.
14. Gossop M. Marsden J. Stewart D. Kidd T. 2003 The National Treatment Outcome Research Study (NTORS): 4-5 year follow-up results Addiction 98 291 303
15. Gostin L. O. 1991 Compulsory treatment for drug dependent persons: justifications for a public health approach to drug dependency The Millbank Quarterly 69 561 593
16. Gottfredson DC. 2001 Schools and Delinquency New York Cambridge University Press
17. Gottfredson DC. Gottfredson GD. 2002 Quality of school-based prevention programs: results from a national survey Journal of Research in Crime and Delinquency 39 3 35
18. Gottfredson D. Nakaja S. Kearly B. 2003 Effectiveness of drug treatment courts: evidence from a randomized trial Criminology and Public Policy 2 171 196
19. Harrell A. Cavanugh S. J. Roman 1998 Findings from the Evaluation of the DCSuperior Court Drug Intervention Program Washington, DC Urban Institute.
20. Hubbard R. Craddock S. Anderson J. 2003 Overview of 5-year followup outcomes in the drug abuse treatment outcome studies (DATOS) Journal of Substance Abuse Treatment 25 125 134
21. Institute of Medicine (IOM 2000 No Time to Lose: Making the Most of HIV Prevention Washington, DC National Academy Press
22. Kleiman M. ( 1993 Against Excess. Drug Policy for Results New York Basic Books
23. Kleiman M. 2001 Controlling drug use and crime with testing, sanctions and treatment In Heymann P. Brownsberger W. eds Drug Addiction and Drug Policy: the Struggle to Control Dependence pp. 168 192 Cambridge Harvard University Press
24. Kuebler D. Hausser D. Gervasoni J-P. 2000 The characteristics of 'new users' of cocaine and heroin unknown to treatment agencies: results from the Swiss Hidden Population Study Addiction 95 1561
25. MacCoun R. P. Reuter 2001 Drug War Heresies: Learning from Other Vices, Times and Places Cambridge Cambridge University Press
26. Manski C. Pepper J. Petrie C. eds. 2001 Informing America's Drug Policy on Illegal Drugs Washington, DC National Academy Press
27. Manski C. Pepper J. Thomas Y. eds 1999 Assessment of Two Cost-Effectiveness Studies on Cocaine Control Policy Washington, DC National Academy Press
28. McLellan AT. 2002 Have we evaluated addiction treatment correctly? Implications from a chronic disease perspective Addiction 97 249 253
29. Metzger D. Woody G. McLellan A. O'Brien C. Druley P. Navaline H. et al. 1993 Human immunodeficiency virus seroconversion among intravenous drug users in- and out-of-treatment: an 18-month prospective follow-up Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology 6 1049 1056
30. National Consensus Development Panel on Effective Medical Treatment of Opiate Addiction 1998 Effective medical treatment of opiate addiction JAMA 280 1936 1943
31. National Drug Monitor 2003 Drug Situation in the Netherlands National Report. Lisbon European Monitoring Center on Drugs and Drug Abuse.
32. Reuter P. MacCoun R. Murphy P. Money from Crime: a Study of the Economics of Drug Dealing in Washington, DC Santa Monica, CA RAND Corporation.
33. Stewart D. Gossop M. Marsden J. 2002 Reductions in non-fatal overdose after drug misuse treatment: results from the National Treatment Outcome Research Study (NTORS) Journal of Substance Abuse Treatment 22 1 9
34. Strang J. McCambridge J. Best D. Beswick T. Bearn J. Rees S. et al. 2003 Loss of tolerance and overdose mortality after inpatient opiate detoxification: follow up study BMJ 326 959 960